Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and aging.

Neural Regen Res · 2025 · PMC11433913 · PMID 38886943

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Food and Drug Administration in 2017 to treat ALS, although clinical trials failed to reach significance between treatment groups.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.